Oxford Nanopore Technologies to participate in January investor conferences

ONT

Oxford Nanopore Technologies plc (LON:ONT), the company delivering a new generation of molecular sensing technology based on nanopores, will be participating in the following investor conferences in January.

·      44th Annual J.P. Morgan Healthcare Conference, San Francisco

Format: Presentation and Q&A session and investor meetings

Date: Monday, 12 January

Time: 2:15pm PT (5:15pm EST/10:15pm GMT)

Webcast: click here to register

·      dbAccess UK & Ireland Conference, London

Format: One-on-one and group investor meetings

Date: Tuesday, 20 January

A live webcast of the J.P. Morgan presentation and Q&A can be accessed at the Company’s investor relations page at: https://nanoporetech.com/about/investors/reports. A webcast replay will be available for at least 30 days following the event via the same link.

Share on:

Latest Company News

Oxford Nanopore lifts gross margin and improves EBITDA in H1 2026

Oxford Nanopore reported higher first-half revenue, improved gross margin and updated its 2030 revenue and EBITDA margin targets.

Oxford Nanopore reports FY2025 revenue ahead of guidance

Oxford Nanopore Technologies expects to report full year 2025 revenue of approximately £223–£224 million, representing around 22% reported growth and 24% growth at constant currency, slightly ahead of guidance.

Oxford Nanopore Technologies to participate in January investor conferences

Oxford Nanopore Technologies will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco and the dbAccess UK & Ireland Conference in London during January.

Oxford Nanopore names Francis Van Parys as new CEO from March 2026

Oxford Nanopore Technologies has appointed Francis Van Parys as Chief Executive Officer, effective 2 March 2026.

Oxford Nanopore CEO Gordon Sanghera to step down

Oxford Nanopore has announced that CEO and co-founder Gordon Sanghera will step down by the end of 2026 after more than 20 years leading the company. The Board has begun a formal search for his successor as part of its succession planning, aiming to guide the business through its next phase of growth and commercialisation.

    Search